Sunday feature: The Australian biotech on the verge of a major breakthrough
FEAR & GREED | Business News
<p>Guest: Mesoblast founder Silviu Itescu</p>
<p>Original air date: March 9, 2022</p>
<p>ASX-listed biotech Mesoblast is spoken about a lot on Fear and Greed due to its extremely volatile share price. This is largely tied to some big medical breakthroughs they've been working on for a long time.</p>
<p>Founder Silviu Itescu discusses the exhaustive and expensive process behind getting critical new drugs developed, tested and approved and the possible announcements that are coming.</p>
<p><em>Update: Mesoblast has been in the news this week. Its share price shot up due to investor excitement over its pending Food & Drug Administration submission.</em></p>
<p><a href="https://fearandgreed.com.au" rel="nofollow">Find out more: https://fearandgreed.com.au</a></p>
<p>See <a href="https://omnystudio.com/listener" rel="nofollow">omnystudio.com/listener</a> for privacy information.</p>